We examined whether long-term exposure to visceral-adipose-tissue (VAT) influences brain atrophy and cognitive performance years after lifestyle intervention. In the Follow-Interventions-Trials (FIT) project, 533 adults (age=61.4 y, 86% men) from four prior 18-24-month lifestyle randomized-clinical-trials underwent abdominal/brain magnetic-resonance-imaging (MRI)s and Montreal-Cognitive-Assessment (MoCA) testing 5-16 y after interventions. Lower VAT exposure, calculated by area-under-the-curve, from baseline, post-intervention, and follow-up, independently resulted in higher MoCA scores. VAT loss during intervention predicted higher brain volumes at follow-up, independent of weight loss. Among participants with three brain and VAT MRI scans, lower long-term VAT was associated with a slower rate of brain atrophy. These patterns were not observed for deep/superficial subcutaneous-adipose-tissues. Improved glycemic control parameters, rather than lipid or inflammatory markers, were mostly related to the favorable longitudinal brain outcomes. This long-term, large-scale intervention and follow-up MRI study suggests that sustained visceral fat loss, rather than weight loss, is linked to better cognition and attenuation of brain atrophy years later, mainly via improved glycemic control. Trial registration: DIRECT (Clinical-trials-identifier: NCT00160108); CASCADE (Clinical-trials-identifier: NCT00784433); CENTRAL (Clinical-trials-identifier: NCT01530724); DIRECT-PLUS (Clinical-trials-identifier: NCT03020186).
{"title":"Sustained visceral fat loss is associated with attenuated brain atrophy and improved cognitive function in late midlife.","authors":"Dafna Pachter,Hadar Klein,Omer Kamer,Dana Tamar Goldberg Toren,Liav Alufer,Noa Ebstein Karamani,Tomer Atlas,Amit Yaary,Idan Hagbi,Yoash Chassidim,Ilan Shelef,Moti Salti,Frauke Beyer,Veronica Witte,Assaf Rudich,Uri Yoel,Gal Ben-Arie,Anat Yaskolka Meir,Alon Kaplan,Gal Tsaban,Hila Zelicha,Carmi Bartal,Lu Qi,Matthias Blüher,Michael Stumvoll,Uta Ceglarek,Berend Isermann,Dong D Wang,Meir J Stampfer,Frank B Hu,Galia Avidan,Iris Shai","doi":"10.1038/s41467-026-71141-4","DOIUrl":"https://doi.org/10.1038/s41467-026-71141-4","url":null,"abstract":"We examined whether long-term exposure to visceral-adipose-tissue (VAT) influences brain atrophy and cognitive performance years after lifestyle intervention. In the Follow-Interventions-Trials (FIT) project, 533 adults (age=61.4 y, 86% men) from four prior 18-24-month lifestyle randomized-clinical-trials underwent abdominal/brain magnetic-resonance-imaging (MRI)s and Montreal-Cognitive-Assessment (MoCA) testing 5-16 y after interventions. Lower VAT exposure, calculated by area-under-the-curve, from baseline, post-intervention, and follow-up, independently resulted in higher MoCA scores. VAT loss during intervention predicted higher brain volumes at follow-up, independent of weight loss. Among participants with three brain and VAT MRI scans, lower long-term VAT was associated with a slower rate of brain atrophy. These patterns were not observed for deep/superficial subcutaneous-adipose-tissues. Improved glycemic control parameters, rather than lipid or inflammatory markers, were mostly related to the favorable longitudinal brain outcomes. This long-term, large-scale intervention and follow-up MRI study suggests that sustained visceral fat loss, rather than weight loss, is linked to better cognition and attenuation of brain atrophy years later, mainly via improved glycemic control. Trial registration: DIRECT (Clinical-trials-identifier: NCT00160108); CASCADE (Clinical-trials-identifier: NCT00784433); CENTRAL (Clinical-trials-identifier: NCT01530724); DIRECT-PLUS (Clinical-trials-identifier: NCT03020186).","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"1 1","pages":""},"PeriodicalIF":16.6,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147518562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C-di-GMP is a widespread second messenger that coordinates transitions between different lifestyles in bacteria. Levels of c-di-GMP are controlled by complex regulatory networks, and they can vary dynamically over a wide range of concentrations. To enable studies of c-di-GMP regulation under a variety of conditions, here we construct and characterize a large set of FRET-based c-di-GMP biosensors that undergo large FRET signal changes and display a stepwise coverage of diverse binding affinities, thus capable of sensitively detecting diverse cellular c-di-GMP concentrations. We subsequently apply different-affinity FRET biosensors from this toolbox to systematically investigate genome-wide network of c-di-GMP regulation in planktonic Escherichia coli cells by establishing FRET-To-Sort, which relies on FRET-based cell sorting of a barcoded transposon library. We observe prominent enrichment of mutations in two classes of flagellar genes among those affecting c-di-GMP levels, and demonstrate that inhibited flagellar rotation reduces biosynthesis of c-di-GMP due to increased proton motive force.
c -二gmp是广泛存在的第二信使,协调细菌不同生活方式之间的过渡。c-二gmp的水平受复杂的调控网络控制,它们可以在很大的浓度范围内动态变化。为了研究多种条件下c-di-GMP的调节,我们构建并表征了一组基于FRET的c-di-GMP生物传感器,这些传感器可以承受较大的FRET信号变化,并显示出不同结合亲和力的逐步覆盖,从而能够灵敏地检测不同的细胞c-di-GMP浓度。随后,我们利用该工具箱中的不同亲和力的FRET生物传感器,通过建立FRET- to - sort,系统地研究了浮游大肠杆菌细胞中c-di-GMP调控的全基因组网络,该网络依赖于基于FRET的条形码转座子库的细胞分选。我们观察到影响c-di-GMP水平的两类鞭毛基因突变显著富集,并证明抑制鞭毛旋转由于质子动力增加而减少了c-di-GMP的生物合成。
{"title":"Toolbox of FRET-based c-di-GMP biosensors and its FRET-To-Sort application for genome-wide mapping of c-di-GMP regulation.","authors":"Liyun Wang,Gabriele Malengo,Ananda Sanches-Medeiros,Xuanlin Chen,Julian Pietsch,Nataliya Teteneva,Silvia González Sierra,Ming C Hammond,Victor Sourjik","doi":"10.1038/s41467-026-71105-8","DOIUrl":"https://doi.org/10.1038/s41467-026-71105-8","url":null,"abstract":"C-di-GMP is a widespread second messenger that coordinates transitions between different lifestyles in bacteria. Levels of c-di-GMP are controlled by complex regulatory networks, and they can vary dynamically over a wide range of concentrations. To enable studies of c-di-GMP regulation under a variety of conditions, here we construct and characterize a large set of FRET-based c-di-GMP biosensors that undergo large FRET signal changes and display a stepwise coverage of diverse binding affinities, thus capable of sensitively detecting diverse cellular c-di-GMP concentrations. We subsequently apply different-affinity FRET biosensors from this toolbox to systematically investigate genome-wide network of c-di-GMP regulation in planktonic Escherichia coli cells by establishing FRET-To-Sort, which relies on FRET-based cell sorting of a barcoded transposon library. We observe prominent enrichment of mutations in two classes of flagellar genes among those affecting c-di-GMP levels, and demonstrate that inhibited flagellar rotation reduces biosynthesis of c-di-GMP due to increased proton motive force.","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"24 1","pages":""},"PeriodicalIF":16.6,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147518676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-26DOI: 10.1038/s41467-026-71178-5
Florian Buchholz,Lina M Upterworth,Leif Tueffers,Espen E Groth,Kira Haas,Daniel Schütz,Abigail Savietto Scholz,Aditi Batra,Surajit Pal,Samarpita Banerjee,Badri N Dubey,Sören Franzenburg,Barbara Kalsdorf,Klaus F Rabe,Dennis Nurjadi,Jan Rupp,Dan I Andersson,Holger Sondermann,Marc Bramkamp,Roderich Roemhild,Hinrich Schulenburg
Antibiotic combination in time and space is a key strategy to combat antimicrobial resistance. The success of such treatment designs requires their robust efficacy across treatment conditions and a pathogen's genomic diversity. This study found that an initial treatment with a β-lactam antibiotic causes robust cellular sensitization towards an aminoglycoside antibiotic across the high-risk human pathogen Pseudomonas aeruginosa, including resistant strains. This phenomenon of cellular sensitization, termed negative hysteresis, is modulated by the Cpx envelope stress response system and linked to membrane stress during growth. The increase in efficacy is achieved through a β-lactam induced elevated cellular uptake of the subsequently administered aminoglycoside. Negative hysteresis and the Cpx system are linked in several cases to the expression of synergistic drug interactions, thus enhancing efficacy of antibiotic combinations. Overall, our study identifies the phenomenon of negative hysteresis as a robustly inducible phenotype and thus a unique focus for optimizing antimicrobial therapy.
{"title":"Robust antibiotic sensitization of pathogenic Pseudomonas aeruginosa via negative hysteresis in the cell envelope.","authors":"Florian Buchholz,Lina M Upterworth,Leif Tueffers,Espen E Groth,Kira Haas,Daniel Schütz,Abigail Savietto Scholz,Aditi Batra,Surajit Pal,Samarpita Banerjee,Badri N Dubey,Sören Franzenburg,Barbara Kalsdorf,Klaus F Rabe,Dennis Nurjadi,Jan Rupp,Dan I Andersson,Holger Sondermann,Marc Bramkamp,Roderich Roemhild,Hinrich Schulenburg","doi":"10.1038/s41467-026-71178-5","DOIUrl":"https://doi.org/10.1038/s41467-026-71178-5","url":null,"abstract":"Antibiotic combination in time and space is a key strategy to combat antimicrobial resistance. The success of such treatment designs requires their robust efficacy across treatment conditions and a pathogen's genomic diversity. This study found that an initial treatment with a β-lactam antibiotic causes robust cellular sensitization towards an aminoglycoside antibiotic across the high-risk human pathogen Pseudomonas aeruginosa, including resistant strains. This phenomenon of cellular sensitization, termed negative hysteresis, is modulated by the Cpx envelope stress response system and linked to membrane stress during growth. The increase in efficacy is achieved through a β-lactam induced elevated cellular uptake of the subsequently administered aminoglycoside. Negative hysteresis and the Cpx system are linked in several cases to the expression of synergistic drug interactions, thus enhancing efficacy of antibiotic combinations. Overall, our study identifies the phenomenon of negative hysteresis as a robustly inducible phenotype and thus a unique focus for optimizing antimicrobial therapy.","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"19 1","pages":""},"PeriodicalIF":16.6,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147518680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-26DOI: 10.1038/s41467-026-71108-5
Huashan Liu, Ze Li, Dongxu Lei, Hao Xie, Xuanhua Yang, Chi Zhou, Shujuan Li, Wenxin Li, Ziwei Zeng, Liang Kang
p53 is crucial for cellular functions and disease mechanisms, yet effective clinical strategies targeting it remain challenging. Lactylation has emerged as a key factor in understanding disease pathology and offering therapeutic options. Herein, we identify lactylated KAT8 at lysine 145 (K145) as a modulator of p53 activity. GCN5 and SIRT6 function as the acyltransferase and delactylase for KAT8, respectively. K145 lactylation fosters the formation of KAT8-TIP60 complex, which couples with p53 to facilitate its acetylation at lysine 120 (K120). The KAT8-TIP60 complex promotes K120-acetylated p53 binding to the BAX and PUMA promoters, activating their transcription. Furthermore, we link KAT8 lactylation to doxorubicin-induced cardiotoxicity (DIC), showing that doxorubicin increases K145 lactylation, amplifying p53's pro-apoptotic function and triggering cardiomyocyte apoptosis. Glimepiride, a therapeutic agent for type 2 diabetes, could target KAT8, disrupt its interaction with GCN5, inhibit KAT8 K145 lactylation, and mitigate DIC. These findings provide insight into how KAT8 K145 lactylation modulates p53 activity and contributes to DIC.
{"title":"Lactylation at lysine 145 fosters KAT8-TIP60 complex formation to promote p53 acetylation at lysine 120 and its pro-apoptotic function.","authors":"Huashan Liu, Ze Li, Dongxu Lei, Hao Xie, Xuanhua Yang, Chi Zhou, Shujuan Li, Wenxin Li, Ziwei Zeng, Liang Kang","doi":"10.1038/s41467-026-71108-5","DOIUrl":"https://doi.org/10.1038/s41467-026-71108-5","url":null,"abstract":"<p><p>p53 is crucial for cellular functions and disease mechanisms, yet effective clinical strategies targeting it remain challenging. Lactylation has emerged as a key factor in understanding disease pathology and offering therapeutic options. Herein, we identify lactylated KAT8 at lysine 145 (K145) as a modulator of p53 activity. GCN5 and SIRT6 function as the acyltransferase and delactylase for KAT8, respectively. K145 lactylation fosters the formation of KAT8-TIP60 complex, which couples with p53 to facilitate its acetylation at lysine 120 (K120). The KAT8-TIP60 complex promotes K120-acetylated p53 binding to the BAX and PUMA promoters, activating their transcription. Furthermore, we link KAT8 lactylation to doxorubicin-induced cardiotoxicity (DIC), showing that doxorubicin increases K145 lactylation, amplifying p53's pro-apoptotic function and triggering cardiomyocyte apoptosis. Glimepiride, a therapeutic agent for type 2 diabetes, could target KAT8, disrupt its interaction with GCN5, inhibit KAT8 K145 lactylation, and mitigate DIC. These findings provide insight into how KAT8 K145 lactylation modulates p53 activity and contributes to DIC.</p>","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":" ","pages":""},"PeriodicalIF":15.7,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147521327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-26DOI: 10.1038/s41467-026-70615-9
Ricardo Rodríguez-Varela, Zoé Pochon, Alex Mas-Sandoval, Reyhan Yaka, Cesar A Fortes-Lima, Almudena García Rubio, Nicholas Márquez-Grant, Juanjo Marí, Glenda Graziani, Antoni Ferrer Abárzuza, Mário Vicente, Lander Lorca-Francisco, Anna Linderholm, Vendela K Lagerholm, Lara R Arauna, Patxi Pérez-Ramallo, Maja Krzewińska, Carina M Schlebusch, Anders Götherström
Ibiza, an island in present-day Spain, was conquered in 902 CE by the Umayyad Emirate of Córdoba. The island remained under Islamic rule until 1235. Here, we analyse the genetic and metagenomic profiles of 13 individuals from an Islamic cemetery in Ibiza, dated to 950-1150 CE. Genome-wide analyses reveal heterogeneity, with ancestry components from Europe, North Africa, and Sub-Saharan Africa. Our analyses estimate that North African gene flow occurred two to seven generations before these individuals lived, suggesting admixture following the Islamic conquest of Iberia and potentially on Ibiza itself. Notably, two individuals trace their Sub-Saharan origins to distinct regions, Senegambia and present-day southern Chad, providing direct evidence of trans-Saharan connections via military and slave networks documented in contemporary Arabic sources. Metagenomic analyses detect several pathogens in this community, with one individual carrying Mycobacterium leprae, offering insight into the presence of leprosy in Ibiza. Our findings align with the historically documented two-pulse demographic model, indicating an initial settlement following the early tenth-century conquest and a second influx associated with Almoravid movements in the twelfth century. These securely dated genomes offer insights into medieval population dynamics and health in the Balearics.
{"title":"Analysis of medieval burials from Ibiza reveals genetic and pathogenic diversity during the Islamic period.","authors":"Ricardo Rodríguez-Varela, Zoé Pochon, Alex Mas-Sandoval, Reyhan Yaka, Cesar A Fortes-Lima, Almudena García Rubio, Nicholas Márquez-Grant, Juanjo Marí, Glenda Graziani, Antoni Ferrer Abárzuza, Mário Vicente, Lander Lorca-Francisco, Anna Linderholm, Vendela K Lagerholm, Lara R Arauna, Patxi Pérez-Ramallo, Maja Krzewińska, Carina M Schlebusch, Anders Götherström","doi":"10.1038/s41467-026-70615-9","DOIUrl":"https://doi.org/10.1038/s41467-026-70615-9","url":null,"abstract":"<p><p>Ibiza, an island in present-day Spain, was conquered in 902 CE by the Umayyad Emirate of Córdoba. The island remained under Islamic rule until 1235. Here, we analyse the genetic and metagenomic profiles of 13 individuals from an Islamic cemetery in Ibiza, dated to 950-1150 CE. Genome-wide analyses reveal heterogeneity, with ancestry components from Europe, North Africa, and Sub-Saharan Africa. Our analyses estimate that North African gene flow occurred two to seven generations before these individuals lived, suggesting admixture following the Islamic conquest of Iberia and potentially on Ibiza itself. Notably, two individuals trace their Sub-Saharan origins to distinct regions, Senegambia and present-day southern Chad, providing direct evidence of trans-Saharan connections via military and slave networks documented in contemporary Arabic sources. Metagenomic analyses detect several pathogens in this community, with one individual carrying Mycobacterium leprae, offering insight into the presence of leprosy in Ibiza. Our findings align with the historically documented two-pulse demographic model, indicating an initial settlement following the early tenth-century conquest and a second influx associated with Almoravid movements in the twelfth century. These securely dated genomes offer insights into medieval population dynamics and health in the Balearics.</p>","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"17 1","pages":""},"PeriodicalIF":15.7,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147521489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-26DOI: 10.1038/s41467-026-70932-z
Mengjing Li, Zhenhai Du, Hanzhen Li, Mingyu Zhang, Yining Liu, Fengyu Zhang, Liangjun Hu, Lichuan Gu, Xiangfeng Chen, Tao Huang, Gang Lu, Wai-Yee Chan, Fei Gao, Zi-Jiang Chen, Wei Xie, Hongbin Liu
During spermatogenesis, the unsynapsed XY chromosomes undergo meiotic sex chromosome inactivation (MSCI) and form a heterochromatic XY body. Defects in MSCI lead to meiotic arrest and male infertility. Although DNA damage response (DDR) factors are established as key initiators of MSCI, how transcriptional silencing is subsequently achieved remains elusive. Here, we identify the nucleolar components NPM1, SENP3, and rRNA as essential downstream effectors of DDR signaling in MSCI. During pachytene, these components migrate to and transiently cover the XY body during MSCI establishment, before becoming restricted to a corner of the XY body. Genetic deletion of Npm1 or Senp3, or inhibition of rRNA transcription severely impairs MSCI. Mechanistically, SENP3-mediated deSUMOylation of NPM1 promotes its interaction with rRNA, enabling liquid-liquid phase separation, via which they exclude Pol II from the XY body. Together, these data reveal a critical role of nucleolar components in the transcriptional regulation of MSCI in mammalian spermatogenesis.
{"title":"Nucleolar migration regulates meiotic sex chromosome inactivation via phase separation during mammalian spermatogenesis.","authors":"Mengjing Li, Zhenhai Du, Hanzhen Li, Mingyu Zhang, Yining Liu, Fengyu Zhang, Liangjun Hu, Lichuan Gu, Xiangfeng Chen, Tao Huang, Gang Lu, Wai-Yee Chan, Fei Gao, Zi-Jiang Chen, Wei Xie, Hongbin Liu","doi":"10.1038/s41467-026-70932-z","DOIUrl":"https://doi.org/10.1038/s41467-026-70932-z","url":null,"abstract":"<p><p>During spermatogenesis, the unsynapsed XY chromosomes undergo meiotic sex chromosome inactivation (MSCI) and form a heterochromatic XY body. Defects in MSCI lead to meiotic arrest and male infertility. Although DNA damage response (DDR) factors are established as key initiators of MSCI, how transcriptional silencing is subsequently achieved remains elusive. Here, we identify the nucleolar components NPM1, SENP3, and rRNA as essential downstream effectors of DDR signaling in MSCI. During pachytene, these components migrate to and transiently cover the XY body during MSCI establishment, before becoming restricted to a corner of the XY body. Genetic deletion of Npm1 or Senp3, or inhibition of rRNA transcription severely impairs MSCI. Mechanistically, SENP3-mediated deSUMOylation of NPM1 promotes its interaction with rRNA, enabling liquid-liquid phase separation, via which they exclude Pol II from the XY body. Together, these data reveal a critical role of nucleolar components in the transcriptional regulation of MSCI in mammalian spermatogenesis.</p>","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":" ","pages":""},"PeriodicalIF":15.7,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147521496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Microtubule nucleation by the γ-tubulin ring complex (γTuRC) is spatiotemporally regulated and in higher eukaryotes is thought to involve a transition from an inactive open to an active closed conformation that matches the microtubule geometry. However, γTuRC activators only promote a partially closed conformation, raising the question of whether complete closure is required for activation. Combining in vitro nucleation assays and cryo-EM, we find that centrosomin motif 1 (CM1), a conserved element of several γTuRC regulators, potently accelerates human γTuRC-mediated microtubule nucleation by facilitating complete closure of γTuRC as the nascent microtubule assembles. A 3.7 Å cryo-EM structure identifies the γTuRC latch and several interactions involved in conformational closure. Notably, the distinct subunits that keep γTuRC open and inactive in higher eukaryotes also participate in its closure and activation. This work provides additional insight into the logic of the human γTuRC architecture and its activation by CM1.
{"title":"Structural basis of human γTuRC closure during CM1-activated microtubule nucleation.","authors":"Marina Serna,Cláudia Brito,Silvia Speroni,Fabian Zimmermann,Andrés Lopez-Perrote,Maria Gili,Cristina Lacasa,Jens Lüders,Thomas Surrey,Oscar Llorca","doi":"10.1038/s41467-026-70773-w","DOIUrl":"https://doi.org/10.1038/s41467-026-70773-w","url":null,"abstract":"Microtubule nucleation by the γ-tubulin ring complex (γTuRC) is spatiotemporally regulated and in higher eukaryotes is thought to involve a transition from an inactive open to an active closed conformation that matches the microtubule geometry. However, γTuRC activators only promote a partially closed conformation, raising the question of whether complete closure is required for activation. Combining in vitro nucleation assays and cryo-EM, we find that centrosomin motif 1 (CM1), a conserved element of several γTuRC regulators, potently accelerates human γTuRC-mediated microtubule nucleation by facilitating complete closure of γTuRC as the nascent microtubule assembles. A 3.7 Å cryo-EM structure identifies the γTuRC latch and several interactions involved in conformational closure. Notably, the distinct subunits that keep γTuRC open and inactive in higher eukaryotes also participate in its closure and activation. This work provides additional insight into the logic of the human γTuRC architecture and its activation by CM1.","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"272 1","pages":""},"PeriodicalIF":16.6,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147518548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-26DOI: 10.1038/s41467-026-70379-2
Xiong Yang,Min Seo Kim,Xinyu Zhu,Md Mesbah Uddin,Tetsushi Nakao,So Mi Jemma Cho,Satoshi Koyama,Tingfeng Xu,Laurens F Reeskamp,Rufan Zhang,Zhaoqi Liu,Yunga A,Paul S de Vries,Ramachandran S Vasan,Eric Boerwinkle,Alanna C Morrison,Bruce M Psaty,Russell P Tracy,Susan R Heckbert,Michael H Cho,Jeong H Yun,Nicholette D Palmer,Donald W Bowden,Joanne M Murabito,Daniel Levy,Nancy L Heard-Costa,George T O'Connor,Lewis C Becker,Brian G Kral,Lisa R Yanek,Laura M Raffield,Bertha Hidalgo,Jerome I Rotter,Stephen S Rich,Kent D Taylor,Wendy S Post,Charles Kooperberg,Alexander P Reiner,Braxton D Mitchell,Sharon L R Kardia,Jennifer A Smith,Patricia A Peyser,Lawrence F Bielak,Dong Keon Yon,Hong-Hee Won,Donna K Arnett,Albert V Smith,Stacey B Gabriel,Patrick T Ellinor, ,Pradeep Natarajan,Minxian Wang,Akl C Fahed
Multiple germline and somatic genomic factors are associated with risk of coronary artery disease, but there is no single measure of risk that integrates all information from a DNA sample. To address this gap, we develop an integrated genomic model that includes six germline and somatic genetic drivers for coronary artery disease, including polygenic risk score, genetically-proxied proteomic/metabolomic risk scores, and clonal hematopoiesis of indeterminate potential. We evaluated its predictive power in the UK Biobank (N = 391,536), and validate it using data from the TOPMed program (N = 34,177). The 10-year coronary artery disease risk based on the integrated genomic model profile ranges from 1.1% to 15.5% in the UK Biobank and from 3.8% to 33.0% in TOPMed, with a more pronounced gradient in males than females. The integrated genomic model captures the cumulative effect of multiple genetic drivers, identifying individuals at high risk for coronary artery disease despite lacking any single high-risk genetic factor, as well as individuals at low risk despite carrying known high-risk factors. In middle age, the integrated genomic model augments the performance of the Pooled Cohort Equations, a clinical risk calculator for coronary artery disease. While the integrated genomic model yields only modest incremental predictive value over polygenic risk score at the population level, it identifies approximately 13% of high-risk individuals not detected by polygenic risk score alone.
{"title":"An integrated germline and somatic genomic model for coronary artery disease.","authors":"Xiong Yang,Min Seo Kim,Xinyu Zhu,Md Mesbah Uddin,Tetsushi Nakao,So Mi Jemma Cho,Satoshi Koyama,Tingfeng Xu,Laurens F Reeskamp,Rufan Zhang,Zhaoqi Liu,Yunga A,Paul S de Vries,Ramachandran S Vasan,Eric Boerwinkle,Alanna C Morrison,Bruce M Psaty,Russell P Tracy,Susan R Heckbert,Michael H Cho,Jeong H Yun,Nicholette D Palmer,Donald W Bowden,Joanne M Murabito,Daniel Levy,Nancy L Heard-Costa,George T O'Connor,Lewis C Becker,Brian G Kral,Lisa R Yanek,Laura M Raffield,Bertha Hidalgo,Jerome I Rotter,Stephen S Rich,Kent D Taylor,Wendy S Post,Charles Kooperberg,Alexander P Reiner,Braxton D Mitchell,Sharon L R Kardia,Jennifer A Smith,Patricia A Peyser,Lawrence F Bielak,Dong Keon Yon,Hong-Hee Won,Donna K Arnett,Albert V Smith,Stacey B Gabriel,Patrick T Ellinor, ,Pradeep Natarajan,Minxian Wang,Akl C Fahed","doi":"10.1038/s41467-026-70379-2","DOIUrl":"https://doi.org/10.1038/s41467-026-70379-2","url":null,"abstract":"Multiple germline and somatic genomic factors are associated with risk of coronary artery disease, but there is no single measure of risk that integrates all information from a DNA sample. To address this gap, we develop an integrated genomic model that includes six germline and somatic genetic drivers for coronary artery disease, including polygenic risk score, genetically-proxied proteomic/metabolomic risk scores, and clonal hematopoiesis of indeterminate potential. We evaluated its predictive power in the UK Biobank (N = 391,536), and validate it using data from the TOPMed program (N = 34,177). The 10-year coronary artery disease risk based on the integrated genomic model profile ranges from 1.1% to 15.5% in the UK Biobank and from 3.8% to 33.0% in TOPMed, with a more pronounced gradient in males than females. The integrated genomic model captures the cumulative effect of multiple genetic drivers, identifying individuals at high risk for coronary artery disease despite lacking any single high-risk genetic factor, as well as individuals at low risk despite carrying known high-risk factors. In middle age, the integrated genomic model augments the performance of the Pooled Cohort Equations, a clinical risk calculator for coronary artery disease. While the integrated genomic model yields only modest incremental predictive value over polygenic risk score at the population level, it identifies approximately 13% of high-risk individuals not detected by polygenic risk score alone.","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"20 1","pages":""},"PeriodicalIF":16.6,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147518669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Image sensors in machine vision systems face significant challenges related to energy efficiency and processing capability when storing, transferring, and processing massive amounts of data. In humans, over 80% of brain-processed information is obtained through the eyes, which are capable of detecting and synchronously processing information with extremely low overall power consumption. Inspired by the biomimetics, we propose a Neuromorphic Electronic-Opto Spatial Temporal Imager (NEOSTI), one of the smallest electronic-opto fully integrated, eye-sized vision systems enabling acquisition and operation in typical indoor/outdoor non-coherent environments, under both natural and artificial lighting conditions without any extra requirement of the light source. NEOSTI combines processing-pre-sensor in optical domain, processing-in-sensor with nonlinear acquisition capability while optical to electronic converting, and processing-near-sensor in electronic domain, enabling parallel data computing capabilities while sensing. NEOSTI also integrates a low complexity Binary Neural Network to process image semantic information. It attains competitive performance in several visual processing tasks.
{"title":"NEOSTI - a neuromorphic electronic-opto spatial-temporal hybrid image sensor.","authors":"Tianyi Liu,Zheng Huang,Xuecheng Wang,Wanxin Shi,Hongwei Chen,Milin Zhang","doi":"10.1038/s41467-026-71091-x","DOIUrl":"https://doi.org/10.1038/s41467-026-71091-x","url":null,"abstract":"Image sensors in machine vision systems face significant challenges related to energy efficiency and processing capability when storing, transferring, and processing massive amounts of data. In humans, over 80% of brain-processed information is obtained through the eyes, which are capable of detecting and synchronously processing information with extremely low overall power consumption. Inspired by the biomimetics, we propose a Neuromorphic Electronic-Opto Spatial Temporal Imager (NEOSTI), one of the smallest electronic-opto fully integrated, eye-sized vision systems enabling acquisition and operation in typical indoor/outdoor non-coherent environments, under both natural and artificial lighting conditions without any extra requirement of the light source. NEOSTI combines processing-pre-sensor in optical domain, processing-in-sensor with nonlinear acquisition capability while optical to electronic converting, and processing-near-sensor in electronic domain, enabling parallel data computing capabilities while sensing. NEOSTI also integrates a low complexity Binary Neural Network to process image semantic information. It attains competitive performance in several visual processing tasks.","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"5 1","pages":""},"PeriodicalIF":16.6,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147518671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
KRAS, a frequently mutated oncogene, has been challenging to target therapeutically. Although covalent inhibitors like sotorasib against KRASG12C have been developed, their efficacy is often limited by acquired resistance. Targeted protein degradation offers a potential solution but has largely relied on large PROTAC molecules. Here, we report DJX-A-KM, a small-molecule degrader of KRASG12C, designed by incorporating an acrylamide warhead into the MRTX849 scaffold. It induces potent and sustained degradation of KRASG12C in cells and in vivo. Mechanistic investigation reveal that degradation is mediated by the ubiquitin-proteasome system, facilitated by covalent engagement with a E3 ligase, FBXO28, at cysteine 98. Antiproliferation assays demonstrate its potent inhibitory effects across multiple KRASG12C-mutant cancer models. This strategy also enables the development of pan-KRAS degraders against a broader spectrum of KRAS mutations. Our work presents a small-molecule degrader recruiting FBXO28 and provides a blueprint for exploring E3 ligases in protein degradation.
{"title":"Small-molecule degraders for oncogenic KRASG12C and pan-KRAS mutations.","authors":"Jianxiong Deng,Shujun Shen,Lei Huang,Fang Xu,Weizhen Huang,Chaoming Huang,Zhang Zhang,Tongzheng Liu,Yi Tan,Zhengqiu Li","doi":"10.1038/s41467-026-71093-9","DOIUrl":"https://doi.org/10.1038/s41467-026-71093-9","url":null,"abstract":"KRAS, a frequently mutated oncogene, has been challenging to target therapeutically. Although covalent inhibitors like sotorasib against KRASG12C have been developed, their efficacy is often limited by acquired resistance. Targeted protein degradation offers a potential solution but has largely relied on large PROTAC molecules. Here, we report DJX-A-KM, a small-molecule degrader of KRASG12C, designed by incorporating an acrylamide warhead into the MRTX849 scaffold. It induces potent and sustained degradation of KRASG12C in cells and in vivo. Mechanistic investigation reveal that degradation is mediated by the ubiquitin-proteasome system, facilitated by covalent engagement with a E3 ligase, FBXO28, at cysteine 98. Antiproliferation assays demonstrate its potent inhibitory effects across multiple KRASG12C-mutant cancer models. This strategy also enables the development of pan-KRAS degraders against a broader spectrum of KRAS mutations. Our work presents a small-molecule degrader recruiting FBXO28 and provides a blueprint for exploring E3 ligases in protein degradation.","PeriodicalId":19066,"journal":{"name":"Nature Communications","volume":"22 1","pages":""},"PeriodicalIF":16.6,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147518681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}